Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis
Costanza Savino(University of Messina), Roberto Bianchi(AOL (United States)), Federica Ubiali(Fondazione IRCCS Istituto Neurologico Carlo Besta), Fulvio Baggi(Fondazione IRCCS Istituto Neurologico Carlo Besta), Michael Brines(Northwell Health), Massimo Rizzi(Mario Negri Institute for Pharmacological Research), Pietro Ghezzi(Brighton and Sussex Medical School), Elena Fumagalli(Fondazione IRCCS Istituto Nazionale dei Tumori), Barbara Gallo(Fondazione IRCCS Istituto Neurologico Carlo Besta), Annamaria Vezzani(Mario Negri Institute for Pharmacological Research), Tiziana Mennini(Mario Negri Institute for Pharmacological Research), Thomas R. Coleman(University of Messina), Sara Barbera(Mario Negri Institute for Pharmacological Research), Paolo Bigini(Mario Negri Institute for Pharmacological Research), Sara Nava(Fondazione IRCCS Istituto Neurologico Carlo Besta), Anthony Cerami(William K. Warren Foundation), Rosetta Pedotti(Fondazione IRCCS Istituto Neurologico Carlo Besta)
Cited by 112
Related Papers
The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1
|Epilepsia|2010|1.7k
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Brain Inflammation in Epilepsy: Experimental and Clinical Evidence
|Epilepsia|2005|1k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k